| Pilaralisib studied in …STUDIED_INderived13 of 13show fewer |
|---|
| → studied in | NCT01587040Phase 1/Phase 2 · completed Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen · 13 trials list this drug (0 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01013324Phase 2 · completed Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma · 13 trials list this drug (0 active) | — | — | Endometrial Neoplasm,Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01042925Phase 1/Phase 2 · completed Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen · 13 trials list this drug (0 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01082068Phase 1/Phase 2 · completed Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer · 13 trials list this drug (0 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01943838Phase 1 · completed A Study of the Safety and Pharmacokinetics of SAR245408 Tablets in Patients With Solid Tumors or Lymphoma · 13 trials list this drug (0 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01357330Phase 1 · completed Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors · 13 trials list this drug (0 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00704392Phase 1 · withdrawn Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors · 13 trials list this drug (0 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01392924Phase 1 · completed Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors · 13 trials list this drug (0 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01436565Phase 1 · completed A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers · 13 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00756847Phase 1 · completed Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors · 13 trials list this drug (0 active) | — | — | Malignant Neoplasm,Lung Non-Small Cell Carcinoma,Ovarian Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00486135Phase 1 · completed Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma · 13 trials list this drug (0 active) | — | — | Malignant Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01240460Phase 1 · completed Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection · 13 trials list this drug (0 active) | — | — | Glioblastoma,Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00692640Phase 1 · completed Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors · 13 trials list this drug (0 active) | — | — | Malignant Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |